相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sitagliptin inhibits the survival, stemness and autophagy of glioma cells, and enhances temozolomide cytotoxicity
Fangting You et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
Metabolic programming in dendritic cells tailors immune responses and homeostasis
Sofie Hedlund Moller et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Signalling dynamics, cell decisions, and homeostatic control in health and disease
Pablo Oriol Valls et al.
CURRENT OPINION IN CELL BIOLOGY (2022)
Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta-analysis
Tong Lin et al.
JOURNAL OF DIABETES INVESTIGATION (2022)
Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?
Petr Busek et al.
CANCERS (2022)
Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication
Marco Gargaro et al.
IMMUNITY (2022)
Phosphonate-Modified Cellulose Nanocrystals Potentiate the Th1 Polarising Capacity of Monocyte-Derived Dendritic Cells via GABA-B Receptor
Marina Bekic et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)
Distinct spatial and temporal roles for Th1, Th2, and Th17 cells in asthma
Weihang Luo et al.
FRONTIERS IN IMMUNOLOGY (2022)
Dendritic Cells Revisited
Mar Cabeza-Cabrerizo et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease
Sherif S. Farag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity
Madhav D. Sharma et al.
IMMUNITY (2021)
Tolerogenic Dendritic Cells in Autoimmunity and Inflammatory Diseases
Octavio Morante-Palacios et al.
TRENDS IN IMMUNOLOGY (2021)
Functional Dissection of CD26 and Its Pharmacological Inhibition by Sitagliptin During Skin Wound Healing
Yue Jiang et al.
MEDICAL SCIENCE MONITOR (2021)
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E-deficient mice
Bo Li et al.
VASCULAR PHARMACOLOGY (2021)
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update
Michael A. Nauck et al.
DIABETES OBESITY & METABOLISM (2021)
Review of Dendritic Cells, Their Role in Clinical Immunology, and Distribution in Various Animal Species
Mohammed Yusuf Zanna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials
Matthew P. Gilbert et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2
Allan Sauvat et al.
CELL DEATH & DISEASE (2020)
Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
Quan Zhuang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Effects of sitagliptin and vitamin D3 on T helper cell transcription factors and cytokine production in clinical subgroups of type 2 diabetes mellitus: highlights upregulation of FOXP3 and IL-37
Zahra Telikani et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2019)
The increased T helper cells proliferation and inflammatory responses in patients with type 2 diabetes mellitus is suppressed by sitagliptin and vitamin D3 in vitro
Elham Mahabadi-Ashtiyani et al.
INFLAMMATION RESEARCH (2019)
KLF-1 orchestrates a xenobiotic detoxification program essential for longevity of mitochondrial mutants
Marija Herholz et al.
NATURE COMMUNICATIONS (2019)
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
Thiago A. Patente et al.
FRONTIERS IN IMMUNOLOGY (2019)
ILT4 functions as a potential checkpoint molecule for tumor immunotherapy
Aiqin Gao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
Carolyn F. Deacon
PEPTIDES (2018)
Elderly dendritic cells respond to LPS/IFN-gamma and CD40L stimulation despite incomplete maturation
Joanne K. Gardner et al.
PLOS ONE (2018)
Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
Proteome analysis identifies L1CAM/CD171 and DPP4/CD26 as novel markers of human skin mast cells
M. Gschwandtner et al.
ALLERGY (2017)
Dendritic cells as gatekeepers of tolerance
Ari Waisman et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Sitagliptin inhibit human lymphocytes proliferation and Thl/Th17 differentiation in vitro
Marcelo Maia Pinheiro et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Sitagliptin: A Review in Type 2 Diabetes
Lesley J. Scott
DRUGS (2017)
Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins
L. Wagner et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
C. Klemann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
DPP-4 Inhibition by Linagliptin Attenuates Obesity-Related Inflammation and Insulin Resistance by Regulating M1/M2 Macrophage Polarization
Fen Zhuge et al.
DIABETES (2016)
The p38 MAPK inhibitor SB203580 differentially modulates LPS-induced interleukin 6 expression in macrophages
Qinghai Shi et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Identification of novel dendritic cell subset markers in human blood
Fabian Schuetz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases
Chunfeng Qu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
The role of dipeptidyl peptidase 4 (DPP4) in the preservation of renal function: DPP4 involvement in hemoglobin expression
Youichi Sato et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Soluble DPP4 originates in part from bone marrow cells and not from the kidney
Zhendi Wang et al.
PEPTIDES (2014)
p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression
Yong Lu et al.
NATURE COMMUNICATIONS (2014)
CD26: A Multi-Purpose Pharmacological Target
Formica Vincenzo et al.
CURRENT CLINICAL PHARMACOLOGY (2014)
Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study
J. D. Price et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation
Jixin Zhong et al.
DIABETES (2013)
CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus
Sang Ah Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
Haiyan Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Sitagliptin Exerts an Antinflammatory Action
Antoine Makdissi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease
Stewart Leung et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis
Yujiang Fang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells
Manuela Brenk et al.
JOURNAL OF IMMUNOLOGY (2009)
Evaluation of 3 Clinical Dendritic Cell Maturation Protocols Containing Lipopolysaccharide and Interferon-γ
Tae Hee Han et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Overview of the Gliptin Class (Dipeptidyl Peptidase-4 Inhibitors) in Clinical Practice
Nancy Bohannon
POSTGRADUATE MEDICINE (2009)
NF-κB plays a major role in the maturation of human dendritic cells induced by NiSO4 but not by DNCB
Nadege Ade et al.
TOXICOLOGICAL SCIENCES (2007)
Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1
Kei Ohnuma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function
Jennifer L. Brogdon et al.
BLOOD (2007)
Differentiation of CD1a- and CD1a+ monocyte-derived dendritic cells is biased by lipid environment and PPARγ
Peter Gogolak et al.
BLOOD (2007)
Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement
T Nakahara et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2006)
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses
GA Herman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Alternative signaling pathways: When, where and why?
YC Gong et al.
FEBS LETTERS (2005)
CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1
K Ohnuma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen
SL Yan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
CD26: A multifunctional integral membrane and secreted protein of activated lymphocytes
MD Gorrell et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung
DC Underwood et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2000)
分享论文
